200,000+ products from a single source!
sales@angenechem.com
3930-83-4 | 2-IODOBENZAMIDE
CAS No: 3930-83-4 Catalog No: AG00C6U3 MDL No:MFCD00099248
Product Description
Catalog Number:
AG00C6U3
Chemical Name:
2-IODOBENZAMIDE
CAS Number:
3930-83-4
Molecular Formula:
C7H6INO
Molecular Weight:
247.0331
MDL Number:
MFCD00099248
IUPAC Name:
2-iodobenzamide
InChI:
InChI=1S/C7H6INO/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,(H2,9,10)
InChI Key:
YEOYYWCXWUDVCX-UHFFFAOYSA-N
SMILES:
NC(=O)c1ccccc1I
NSC Number:
136970
Properties
Complexity:
138
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
246.949g/mol
Formal Charge:
0
Heavy Atom Count:
10
Hydrogen Bond Acceptor Count:
1
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
247.035g/mol
Monoisotopic Mass:
246.949g/mol
Rotatable Bond Count:
1
Topological Polar Surface Area:
43.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.9
Literature
| Title | Journal |
|---|---|
| SPECT molecular imaging in Parkinson's disease. | Journal of biomedicine & biotechnology 20120101 |
| Synthesis of cytimidine through a one-pot copper-mediated amidation cascade. | Organic letters 20111007 |
| Imaging of the pituitary: Recent advances. | Indian journal of endocrinology and metabolism 20110901 |
| Molecular SPECT Imaging: An Overview. | International journal of molecular imaging 20110101 |
| Preliminary studies of differential impairments of the dopaminergic system in subtypes of progressive supranuclear palsy. | Nuclear medicine communications 20101101 |
| Cortical and subcortical patterns of I-123 iodobenzamide SPECT in striatal D(2) receptor parkinsonisms. | Clinical nuclear medicine 20100401 |
| Preparation and biological evaluation of cyclopentadienyl-based 99mTc-complexes [(Cp-R)99mTc(CO)3] mimicking benzamides for malignant melanoma targeting. | Nuclear medicine and biology 20100401 |
| Targeting murine heart and brain: visualisation conditions for multi-pinhole SPECT with (99m)Tc- and (123)I-labelled probes. | European journal of nuclear medicine and molecular imaging 20090901 |
| Pharmacology and therapeutic potential of sigma(1) receptor ligands. | Current neuropharmacology 20081201 |
| Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070115 |
| Novel alpha,alpha-difluorohomophthalimides via copper-catalyzed tandom cross-coupling-cyclization of 2-halobenzamides with alpha,alpha-difluoro Reformatskii reagent. | The Journal of organic chemistry 20050610 |
| High resolution magic angle spinning NMR spectroscopy used to investigate the ability of drugs to bind to synthetic melanin. | Pigment cell research 20050201 |
| Ultra-structural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciences. | Biomedical engineering online 20040101 |
| Synthesis and affinity of a possible byproduct of electrophilic radiolabeling of [123I]IBZM. | Bioorganic & medicinal chemistry letters 20031117 |
| Synthesis and structure of amino acid-derived benziodazoles: new hypervalent iodine heterocycles. | Organic letters 20030501 |
| Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20021201 |
| Is increased D2 receptor availability associated with response to stimulant medication in ADHD. | Developmental medicine and child neurology 20011101 |
Related Products
© 2019 Angene International Limited. All rights Reserved.